In 2012 UBC CPD received the Royal College Accredited CPD Provider Innovation Award for This Changed My Practice.
Archives by date
You are browsing the site archives by date.
By Dr. Mustafa Toma on April 15, 2013
Spironolactone or eplerenone should be added to BB and ACEi/ARB in NYHA class II HF patients with EF < 30-35% in the absence of significant renal impairment or hyperkalemia.
By Dr. Michelle Withers on April 1, 2013
It is well recognized that AD patients have very dry skin as part of their clinical picture. As such, a very important part of discussing the treatment of AD includes the importance of moisturizing the skin on a regular basis to try to ameliorate dryness.